a16z Live · 18 March 2021
a16z Bio + Health #6: AI for Biologics With Mark DePristo and Peyton Greenside
GuestsJorge CondeJorge CondeGeneral PartnerInvests in therapeutics, diagnostics, tools and software for Andreessen Horowitz's Bio + Health team; earlier chief strategy, financial and product officer at Syros.Julie YooJulie YooGeneral PartnerInvests in healthcare access and payment for Andreessen Horowitz's Bio + Health team; co-founded Kyruus and was its chief product officer.Vineeta AgarwalaVineeta AgarwalaGeneral PartnerPhysician and scientist who leads investments in biotech, life sciences software and digital health for Andreessen Horowitz's Bio + Health fund; earlier on GV's life sciences team.
At the source: Andreessen Horowitz ↗ · audio
From the show notes
On this episode of the a16z Bio Clubhouse Show "It's Time to Heal", a16z general partners Vineeta Agarwala, Jorge Conde, Julie Yoo, and Vijay Pande talk to guests Peyton Greenside and Mark DePristo of BigHat Biosciences. The conversation covers the growing role of artificial intelligence and machine learning in drug development and specifically in biologics and protein therapeutics.
As published with the episode at a16z Live ↗
Summary
No summary of this episode yet.